|
Volumn 51, Issue 6, 1995, Pages 341-346
|
Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins
a a a |
Author keywords
androgens; gestodene; norgestimate; oral contraceptives; serum binding proteins
|
Indexed keywords
ANDROSTANEDIONE;
ETHINYLESTRADIOL PLUS GESTODENE;
ETHINYLESTRADIOL PLUS NORGESTIMATE;
SEX HORMONE BINDING GLOBULIN;
TESTOSTERONE;
ADULT;
ANDROGEN METABOLISM;
ANDROSTENEDIONE BLOOD LEVEL;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG FORMULATION;
FEMALE;
HORMONAL CONTRACEPTION;
HORMONAL REGULATION;
HORMONE PROTEIN COMPLEX;
HUMAN;
HUMAN EXPERIMENT;
HYDROCORTISONE BLOOD LEVEL;
NORMAL HUMAN;
ORAL CONTRACEPTION;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
TESTOSTERONE BLOOD LEVEL;
ADRENAL CORTEX HORMONES;
ANDROGENS;
BIOLOGY;
CLINICAL RESEARCH;
COMPARATIVE STUDIES;
CONTRACEPTION;
CONTRACEPTIVE AGENTS;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVE AGENTS, PROGESTIN;
CONTRACEPTIVE METHODS;
DEVELOPED COUNTRIES;
ENDOCRINE SYSTEM;
EUROPE;
FAMILY PLANNING;
GERMANY;
GESTODENE;
HORMONES;
METABOLIC EFFECTS;
NORGESTIMATE;
ORAL CONTRACEPTIVES;
ORAL CONTRACEPTIVES, COMBINED;
ORAL CONTRACEPTIVES, PHASIC;
PHYSIOLOGY;
RESEARCH METHODOLOGY;
RESEARCH REPORT;
STEROID METABOLIC EFFECTS;
STUDIES;
WESTERN EUROPE;
ADOLESCENT;
ADULT;
ANDROGENS;
ANDROSTANE-3,17-DIOL;
ANDROSTENEDIONE;
CARRIER PROTEINS;
CONTRACEPTIVES, ORAL;
CONTRACEPTIVES, ORAL, COMBINED;
DEHYDROEPIANDROSTERONE;
DEHYDROEPIANDROSTERONE SULFATE;
ESTRADIOL CONGENERS;
ETHINYL ESTRADIOL;
FEMALE;
HUMANS;
HYDROCORTISONE;
NORGESTREL;
NORPREGNENES;
RADIOIMMUNOASSAY;
SEX HORMONE-BINDING GLOBULIN;
TESTOSTERONE;
|
EID: 0029001359
PISSN: 00107824
EISSN: None
Source Type: Journal
DOI: 10.1016/0010-7824(95)00098-U Document Type: Article |
Times cited : (95)
|
References (19)
|